Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone.

Moes AD, Severs D, Verdonk K, van der Lubbe N, Zietse R, Danser AHJ, Hoorn EJ.

Front Physiol. 2018 May 18;9:578. doi: 10.3389/fphys.2018.00578. eCollection 2018.

2.

Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia: Continuous Versus Cutoff Values.

Saleh L, Vergouwe Y, van den Meiracker AH, Verdonk K, Russcher H, Bremer HA, Versendaal HJ, Steegers EAP, Danser AHJ, Visser W.

Hypertension. 2017 Nov;70(5):1025-1033. doi: 10.1161/HYPERTENSIONAHA.117.09913. Epub 2017 Aug 28.

PMID:
28847893
3.

Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.

Saleh L, van den Meiracker AH, Geensen R, Kaya A, Roeters van Lennep JE, Duvekot JJ, Verdonk K, Steegers EAP, Russcher H, Danser AHJ, Visser W.

Ultrasound Obstet Gynecol. 2018 Jun;51(6):751-757. doi: 10.1002/uog.17547. Epub 2018 May 6.

4.

The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort.

Saleh L, Verdonk K, Jan Danser AH, Steegers EA, Russcher H, van den Meiracker AH, Visser W.

Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:121-6. doi: 10.1016/j.ejogrb.2016.02.013. Epub 2016 Feb 18.

PMID:
26927894
5.

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.

Saleh L, Verdonk K, Visser W, van den Meiracker AH, Danser AH.

Ther Adv Cardiovasc Dis. 2016 Oct;10(5):282-93. doi: 10.1177/1753944715624853. Epub 2016 Jan 10. Review.

6.

Meniscal transplantation: still experimental surgery? A review.

Moens K, Dhollander A, Moens P, Verdonk K, Verdonk R, Almqvist KF, Victor J.

Acta Orthop Belg. 2014 Sep;80(3):403-13. Review.

PMID:
26280615
7.

Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression.

Verdonk K, Saleh L, Lankhorst S, Smilde JE, van Ingen MM, Garrelds IM, Friesema EC, Russcher H, van den Meiracker AH, Visser W, Danser AH.

Hypertension. 2015 Jun;65(6):1316-23. doi: 10.1161/HYPERTENSIONAHA.115.05267. Epub 2015 Apr 13.

PMID:
25870197
8.

Variation of urinary protein to creatinine ratio during the day in women with suspected pre-eclampsia.

Verdonk K, Niemeijer IC, Hop WC, de Rijke YB, Steegers EA, van den Meiracker AH, Visser W.

BJOG. 2014 Dec;121(13):1660-5. doi: 10.1111/1471-0528.12803. Epub 2014 Apr 25.

9.

Methodologic issues in the measurement of urinary renin.

Roksnoer LC, Verdonk K, Garrelds IM, van Gool JM, Zietse R, Hoorn EJ, Danser AH.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1163-7. doi: 10.2215/CJN.12661213. Epub 2014 Apr 17.

10.

The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad.

Verdonk K, Visser W, Van Den Meiracker AH, Danser AH.

Clin Sci (Lond). 2014 Apr;126(8):537-44. doi: 10.1042/CS20130455. Review.

PMID:
24400721
11.

Are aldosterone levels inappropriately low in preeclampsia?

Verdonk K, Visser W, van den Meiracker AH, Danser AH.

Hypertension. 2013 Nov;62(5):e39. doi: 10.1161/HYPERTENSIONAHA.113.02006. Epub 2013 Sep 30. No abstract available.

PMID:
24082063
12.

New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.

Krop M, Lu X, Verdonk K, Schalekamp MA, van Gool JM, McKeever BM, Gregg R, Danser AH.

Hypertension. 2013 May;61(5):1075-82. doi: 10.1161/HYPERTENSIONAHA.111.00967. Epub 2013 Mar 4.

PMID:
23460288
13.

Urinary markers of intrarenal renin-angiotensin system activity in vivo.

Roksnoer LC, Verdonk K, van den Meiracker AH, Hoorn EJ, Zietse R, Danser AH.

Curr Hypertens Rep. 2013 Apr;15(2):81-8. doi: 10.1007/s11906-012-0326-z. Review.

PMID:
23296471
14.

Key developments in renin-angiotensin-aldosterone system inhibition.

Sevá Pessôa B, van der Lubbe N, Verdonk K, Roks AJ, Hoorn EJ, Danser AH.

Nat Rev Nephrol. 2013 Jan;9(1):26-36. doi: 10.1038/nrneph.2012.249. Epub 2012 Nov 20. Review.

PMID:
23165302
15.

Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio.

Verdonk K, Visser W, Russcher H, Danser AH, Steegers EA, van den Meiracker AH.

Hypertension. 2012 Oct;60(4):884-90. doi: 10.1161/HYPERTENSIONAHA.112.201459. Epub 2012 Aug 14. No abstract available.

PMID:
22892815
16.

Compound 21 induces vasorelaxation via an endothelium- and angiotensin II type 2 receptor-independent mechanism.

Verdonk K, Durik M, Abd-Alla N, Batenburg WW, van den Bogaerdt AJ, van Veghel R, Roks AJ, Danser AH, van Esch JH.

Hypertension. 2012 Sep;60(3):722-9. doi: 10.1161/HYPERTENSIONAHA.112.196022. Epub 2012 Jul 16.

PMID:
22802221
17.

PP027. Variation of urinary protein/creatinine ratio during the day in women suspected for preeclampsia.

Verdonk K, Hop WC, de Rijke YB, Niemeijer IC, Steegers EA, Visser W.

Pregnancy Hypertens. 2012 Jul;2(3):257. doi: 10.1016/j.preghy.2012.04.138. Epub 2012 Jun 13. No abstract available.

PMID:
26105350
18.

Nucleotide excision DNA repair is associated with age-related vascular dysfunction.

Durik M, Kavousi M, van der Pluijm I, Isaacs A, Cheng C, Verdonk K, Loot AE, Oeseburg H, Bhaggoe UM, Leijten F, van Veghel R, de Vries R, Rudez G, Brandt R, Ridwan YR, van Deel ED, de Boer M, Tempel D, Fleming I, Mitchell GF, Verwoert GC, Tarasov KV, Uitterlinden AG, Hofman A, Duckers HJ, van Duijn CM, Oostra BA, Witteman JC, Duncker DJ, Danser AH, Hoeijmakers JH, Roks AJ.

Circulation. 2012 Jul 24;126(4):468-78. doi: 10.1161/CIRCULATIONAHA.112.104380. Epub 2012 Jun 15.

19.

Angiotensin II type 2 receptor agonists: where should they be applied?

Verdonk K, Danser AH, van Esch JH.

Expert Opin Investig Drugs. 2012 Apr;21(4):501-13. doi: 10.1517/13543784.2012.664131. Epub 2012 Feb 21. Review.

PMID:
22348403
20.

Reactive oxygen species and angiotensin II response in human omental arteries: what about tachyphylaxis?

Verdonk K, Danser AH.

Hypertension. 2012 Feb;59(2):e16; author reply e17. doi: 10.1161/HYPERTENSIONAHA.111.187187. Epub 2011 Dec 5. No abstract available.

PMID:
22146508
21.

Long-term use of aldosterone-receptor antagonists in uncontrolled hypertension: a retrospective analysis.

Jansen PM, Verdonk K, Imholz BP, Jan Danser AH, van den Meiracker AH.

Int J Hypertens. 2011;2011:368140. doi: 10.4061/2011/368140. Epub 2011 Mar 23.

22.

[New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].

Verdonk K, Visser W, Steegers EA, Kappers M, Danser AH, van den Meiracker AH.

Ned Tijdschr Geneeskd. 2011;155:A2946. Review. Dutch.

PMID:
21486506

Supplemental Content

Loading ...
Support Center